Insider Purchases of Penny Stocks -
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-10-07 | ADFS | American Defense Systems Inc | Ea Armament & Surveillance Technologies Inc. | Acting General Manager, 10% | P - Purchase | $0.02 | +4,822,152 | 10,812,152 | +81% | +$106,087 | ||||||
| M | 2019-09-12 | ALRN | Aileron Therapeutics Inc | Von Rickenbach Josef H | Dir | P - Purchase | $0.98 | +113,145 | 218,188 | +108% | +$110,505 | |||||
2019-09-13 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Dir | P - Purchase | $4.10 | +15,000 | 906,544 | +2% | +$61,500 | ||||||
2019-09-13 | ANIX | Anixa Biosciences Inc | Kumar Amit | CEO | P - Purchase | $4.12 | +10,000 | 174,000 | +6% | +$41,200 | ||||||
2019-09-13 | BASI | Bioanalytical Systems Inc | Leasure Robert Jr. | Pres, CEO | P - Purchase | $3.72 | +26,846 | 164,965 | +19% | +$99,867 | ||||||
2019-09-13 | BASI | Bioanalytical Systems Inc | Pitchford William D | CHRO | P - Purchase | $3.70 | +12,000 | 22,000 | +120% | +$44,400 | ||||||
2019-10-07 | BBW | Build A Bear Workshop Inc | Kanen David | Dir | P - Purchase | $3.38 | +4,900 | 1,477,123 | 0% | +$16,562 | ||||||
2019-09-24 | BBW | Build A Bear Workshop Inc | Kanen David | Dir | P - Purchase | $2.89 | +9,800 | 1,469,223 | +1% | +$28,314 | ||||||
| M | 2019-10-03 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $3.47 | +5,700 | 159,011 | +4% | +$19,771 | |||||
| M | 2019-09-27 | BHTG | Biohitech Global, Inc. | Chambers James D. | Dir | P - Purchase | $1.79 | +17,000 | 146,834 | +13% | +$30,503 | |||||
| M | 2019-10-08 | BNED | Barnes & Noble Education, Inc. | Outerbridge Master Fund LP | 10% | P - Purchase | $3.20 | +102,726 | 6,499,621 | +2% | +$328,535 | |||||
| M | 2019-09-27 | BNED | Barnes & Noble Education, Inc. | Outerbridge Master Fund LP | 10% | P - Purchase | $3.14 | +59,328 | 5,920,908 | +1% | +$186,280 | |||||
| M | 2019-09-18 | BNED | Barnes & Noble Education, Inc. | Outerbridge Master Fund LP | 10% | P - Purchase | $3.21 | +1,073,216 | 5,861,580 | +22% | +$3,440,001 | |||||
| M | 2019-10-02 | BNED | Barnes & Noble Education, Inc. | Outerbridge Master Fund LP | 10% | P - Purchase | $3.01 | +475,987 | 6,396,895 | +8% | +$1,432,111 | |||||
2019-09-13 | BSQR | Bsquare Corp /wa | Vardeman Ryan L. | Dir | P - Purchase | $1.29 | +10,484 | 1,236,735 | +1% | +$13,535 | ||||||
| M | 2019-10-07 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.84 | +5,054 | 3,884,655 | 0% | +$14,329 | |||||
| M | 2019-09-30 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $3.14 | +4,426 | 3,878,172 | 0% | +$13,915 | |||||
| M | 2019-09-12 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.97 | +3,919 | 3,858,198 | 0% | +$11,633 | |||||
| M | 2019-09-26 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $3.24 | +3,542 | 3,873,746 | 0% | +$11,468 | |||||
| M | 2019-09-16 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.90 | +5,635 | 3,863,833 | 0% | +$16,360 | |||||
| M | 2019-09-23 | BTN | Ballantyne Strong, Inc. | Fundamental Global Investors, LLC | Dir, 10% | P - Purchase | $2.96 | +4,242 | 3,870,204 | 0% | +$12,572 | |||||
2019-09-18 | BVSN | Broadvision Inc | Esw Capital, LLC | 10% | P - Purchase | $1.33 | +46,088 | 1,045,307 | +5% | +$61,302 | ||||||
2019-08-23 | CATN | Cat9 Group Inc. | Sun Wenfa Simon | Pres, CEO, 10% | P - Purchase | $0.01 | +10,000,000 | 80,000,000 | +14% | +$98,000 | ||||||
2019-09-24 | CDTX | Cidara Therapeutics, Inc. | Stein Jeffrey | Pres, CEO | P - Purchase | $1.91 | +52,500 | 523,648 | +11% | +$100,102 | ||||||
2019-09-24 | CDTX | Cidara Therapeutics, Inc. | Levine James E. | CFO | P - Purchase | $1.91 | +30,000 | 205,000 | +17% | +$57,240 | ||||||
| D | 2019-09-12 | CELH | Celsius Holdings, Inc. | Chau Hoi Shuen Solina Holly | 10% | P - Purchase | $3.60 | +222,222 | 6,279,964 | +4% | +$799,999 | |||||
| D | 2019-09-12 | CELH | Celsius Holdings, Inc. | Li Ka Shing | 10% | P - Purchase | $3.60 | +333,333 | 9,066,014 | +4% | +$1,199,999 | |||||
2019-09-27 | CHMA | Chiasma, Inc | Ludlam William | See Remarks | P - Purchase | $4.91 | +5,050 | 11,799 | +75% | +$24,783 | ||||||
2019-09-12 | CHRA | Charah Solutions, Inc. | Sewell Scott Andrew | Pres, CEO | P - Purchase | $2.62 | +14,000 | 385,934 | +4% | +$36,688 | ||||||
| M | 2019-09-25 | CLOK | Cipherloc Corp | Manchester Management Pr, LLC | 10% | P - Purchase | $0.54 | +100,000 | 4,250,400 | +2% | +$53,700 | |||||
2019-09-16 | CLUB | Town Sports International Holdings Inc | Walsh Patrick | CEO, 10% | P - Purchase | $1.96 | +16,607 | 3,771,616 | 0% | +$32,550 | ||||||
2019-10-03 | CPRX | Catalyst Pharmaceuticals, Inc. | McEnany Patrick J | Pres, CEO | P - Purchase | $4.89 | +10,000 | 4,772,693 | 0% | +$48,900 | ||||||
2019-10-11 | CPRX | Catalyst Pharmaceuticals, Inc. | O'Keeffe Charles B | Dir | P - Purchase | $4.70 | +10,000 | 553,376 | +2% | +$46,950 | ||||||
2019-09-17 | CTDH | Ctd Holdings Inc | Shanahan William S | Dir | P - Purchase | $0.19 | +147,200 | 2,667,660 | +6% | +$27,968 | ||||||
2019-09-16 | CTDH | Ctd Holdings Inc | Ostronic Francis Patrick | Dir | P - Purchase | $0.19 | +100,000 | 1,355,890 | +8% | +$19,000 | ||||||
2019-09-16 | CTHR | Charles & Colvard Ltd | Miglucci Suzanne | Pres, CEO | P - Purchase | $1.34 | +7,500 | 497,113 | +2% | +$10,050 | ||||||
| D | 2019-09-27 | CTXR | Citius Pharmaceuticals, Inc. | Mazur Leonard L | Exec COB, 10% | P - Purchase | $0.90 | +2,234,700 | 10,255,343 | +28% | +$2,000,280 | |||||
| D | 2019-09-27 | CTXR | Citius Pharmaceuticals, Inc. | Holubiak Myron Z | Pres, CEO, 10% | P - Purchase | $0.90 | +558,597 | 1,992,243 | +39% | +$500,000 | |||||
2019-09-12 | CUI | Cui Global, Inc. | Cochennet Steve | Dir | P - Purchase | $0.75 | +28,169 | 90,289 | +45% | +$21,163 | ||||||
| A | 2019-09-13 | DMPI | Delmar Pharmaceuticals, Inc. | Bell John K | Dir | P - Purchase | $0.68 | +35,000 | 44,701 | +361% | +$23,744 | |||||
2019-09-13 | DMPI | Delmar Pharmaceuticals, Inc. | Bell John K | Dir | P - Purchase | $0.68 | +35,000 | 44,701 | +361% | +$23,744 | ||||||
| M | 2019-09-18 | DPW | Dpw Holdings, Inc. | Gu Ding | 10% | P - Purchase | $2.77 | +40,000 | 225,000 | +22% | +$110,850 | |||||
2019-09-13 | DSKE | Daseke, Inc. | Serianni Charles F | Dir | P - Purchase | $3.43 | +10,000 | 10,000 | New | +$34,300 | ||||||
2019-09-20 | DXLG | Destination Xl Group, Inc. | Holtzman Seymour | Dir | P - Purchase | $1.44 | +16,271 | 4,736,711 | 0% | +$23,455 | ||||||
2019-09-19 | DXLG | Destination Xl Group, Inc. | Holtzman Seymour | Dir | P - Purchase | $1.35 | +12,000 | 4,720,440 | 0% | +$16,200 | ||||||
2019-09-19 | DXLG | Destination Xl Group, Inc. | Reaves Brian | EVP, COO | P - Purchase | $1.35 | +21,735 | 136,469 | +19% | +$29,429 | ||||||
2019-09-19 | DXLG | Destination Xl Group, Inc. | Kanter Harvey S | Pres, CEO | P - Purchase | $1.39 | +20,000 | 30,000 | +200% | +$27,780 | ||||||
2019-09-18 | DXLG | Destination Xl Group, Inc. | Holtzman Seymour | Dir | P - Purchase | $1.40 | +20,000 | 4,708,440 | 0% | +$27,960 | ||||||
2019-09-17 | DXLG | Destination Xl Group, Inc. | Holtzman Seymour | Dir | P - Purchase | $1.41 | +9,000 | 4,688,440 | 0% | +$12,690 | ||||||
| M | 2019-09-24 | EMMA | Emmaus Life Sciences, Inc. | Niihara Yutaka | COB, CEO, 10% | P - Purchase | $2.13 | +10,000 | 10,389,087 | 0% | +$21,300 | |||||
| M | 2019-09-12 | EVOL | Evolving Systems Inc | Nicol David J | Dir | P - Purchase | $0.84 | +16,999 | 161,944 | +12% | +$14,273 | |||||
| DM | 2019-09-29 | EYEG | Eyegate Pharmaceuticals Inc | Armistice Capital, LLC | Dir, 10% | P - Purchase | $3.12 | +605,001 | 3,585,000 | +20% | +$1,890,613 | |||||
| M | 2019-09-26 | FPAY | Flexshopper, Inc. | Dvorkin Howard | Dir, 10% | P - Purchase | $1.53 | +132,045 | 1,558,439 | +9% | +$201,561 | |||||
| M | 2019-10-04 | FPRX | Five Prime Therapeutics, Inc. | Bvf Partners L P/il | 10% | P - Purchase | $3.74 | +601,482 | 342,843 | -233% | +$2,250,962 | |||||
2019-09-25 | FTEK | Fuel Tech, Inc. | Cummings William E Jr | SVP, Sales | P - Purchase | $0.96 | +21,511 | 232,864 | +10% | +$20,616 | ||||||
2019-09-26 | FTEK | Fuel Tech, Inc. | Cummings William E Jr | SVP, Sales | P - Purchase | $0.97 | +28,489 | 261,353 | +12% | +$27,546 | ||||||
| M | 2019-09-13 | FTK | Flotek Industries Inc/cn/ | Nierenberg David | Dir | P - Purchase | $2.51 | +113,500 | 2,514,062 | +5% | +$284,418 | |||||
2019-09-20 | GME | Gamestop Corp. | Teffner Carrie W. | Dir | P - Purchase | $4.73 | +21,118 | 55,469 | +61% | +$99,888 | ||||||
2019-09-18 | GME | Gamestop Corp. | Fernandez Raul J | Dir | P - Purchase | $4.62 | +5,250 | 33,219 | +19% | +$24,255 | ||||||
| AM | 2019-09-20 | GNLN | Greenlane Holdings, Inc. | Pura Vida Investments, LLC | 10% | P - Purchase | $4.25 | +75,000 | 1,207,890 | +7% | +$318,950 | |||||
| M | 2019-09-20 | GNLN | Greenlane Holdings, Inc. | Pura Vida Investments, LLC | 10% | P - Purchase | $4.25 | +75,000 | 25,000 | -150% | +$318,950 | |||||
2019-09-30 | GNLN | Greenlane Holdings, Inc. | Pura Vida Investments, LLC | 10% | P - Purchase | $3.39 | +10,000 | 1,217,890 | +1% | +$33,900 | ||||||
| M | 2019-09-26 | GNLN | Greenlane Holdings, Inc. | Taney Richard | Dir | P - Purchase | $3.65 | +30,000 | 35,000 | +600% | +$109,350 | |||||
| M | 2019-09-27 | HGBL | Heritage Global Inc. | Hexner Michael | Dir | P - Purchase | $0.80 | +26,026 | 15 | -100% | +$20,893 | |||||
2019-09-13 | HIL | Hill International, Inc. | Chadwick James M | Dir | P - Purchase | $2.95 | +12,665 | 131,599 | +11% | +$37,362 | ||||||
2019-10-07 | HNRG | Hallador Energy Co | Hardie David C | Dir | P - Purchase | $3.29 | +30,380 | 169,469 | +22% | +$100,002 | ||||||
2019-08-28 | IMLE | Transbiotec, Inc. | Mishal Devadatt M | Dir | P - Purchase | $0.00 | +13,134,420 | 20,534,857 | +177% | +$53,851 | ||||||
2019-08-28 | IMLE | Transbiotec, Inc. | Lanphere Michael A. | VP of Legal Affairs, 10% | P - Purchase | $0.02 | +26,607,175 | 71,545,623 | +59% | +$616,946 | ||||||
| M | 2019-09-12 | IMTL | Image Protect, Inc. | Lawrence Adams | CEO | P - Purchase | $0.00 | +10,355,000 | 28,317,949 | +58% | +$14,202 | |||||
| M | 2019-09-16 | INNV | Innovus Pharmaceuticals, Inc. | Armistice Capital, LLC | 10% | P - Purchase | $2.56 | +18,183 | 600,000 | +3% | +$46,624 | |||||
2019-09-17 | IWSY | Imageware Systems Inc | Miller S James | COB, CEO | P - Purchase | $0.49 | +30,000 | 984,808 | +3% | +$14,700 | ||||||
| M | 2019-09-23 | KIRK | Kirkland'S, Inc | Cairnes Mike | Pres, COO | P - Purchase | $1.37 | +12,110 | 132,634 | +10% | +$16,585 | |||||
2019-09-24 | KMPH | Kempharm, Inc | Mickle Travis C | Pres, CEO, 10% | P - Purchase | $0.79 | +50,000 | 2,259,334 | +2% | +$39,382 | ||||||
| M | 2019-09-12 | LIVX | Livexlive Media, Inc. | Ellin Robert S | CEO, COB, 10% | P - Purchase | $2.66 | +5,121 | 17,393,362 | 0% | +$13,600 | |||||
| M | 2019-09-13 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $2.69 | +103,042 | 4,634,631 | +2% | +$277,591 | |||||
2019-09-13 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $2.40 | +197,473 | 4,531,589 | +5% | +$474,760 | ||||||
2019-09-16 | LXRX | Lexicon Pharmaceuticals, Inc. | Sobecki Christopher J | Dir | P - Purchase | $2.55 | +25,000 | 137,293 | +22% | +$63,718 | ||||||
2019-09-18 | LXRX | Lexicon Pharmaceuticals, Inc. | Coats Lonnel | Pres, CEO | P - Purchase | $3.10 | +50,000 | 227,539 | +28% | +$155,000 | ||||||
2019-09-18 | LXRX | Lexicon Pharmaceuticals, Inc. | Santini Alexander A | EVP, CCO | P - Purchase | $3.36 | +4,500 | 18,661 | +32% | +$15,115 | ||||||
2019-09-17 | LXRX | Lexicon Pharmaceuticals, Inc. | Coats Lonnel | Pres, CEO | P - Purchase | $3.13 | +50,000 | 177,539 | +39% | +$156,403 | ||||||
2019-09-13 | LXRX | Lexicon Pharmaceuticals, Inc. | Sobecki Christopher J | Dir | P - Purchase | $2.41 | +99,249 | 112,293 | +761% | +$238,750 | ||||||
2019-09-03 | MCCX | McOrpcx, Inc. | Davison Lynn L | COO | P - Purchase | $0.05 | +300,000 | 300,000 | New | +$15,000 | ||||||
| D | 2019-09-13 | MCF | Contango Oil & Gas Co | Goff John C | Dir, 10% | P - Purchase | $0.95 | +18,421,052 | 25,304,325 | +268% | +$17,499,999 | |||||
| DM | 2019-09-24 | MCHX | Marchex Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $3.31 | +63,673 | 10,568,719 | +1% | +$210,662 | |||||
| DM | 2019-09-17 | MCHX | Marchex Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $3.27 | +37,350 | 10,457,322 | 0% | +$121,953 | |||||
| DM | 2019-09-27 | MCHX | Marchex Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $3.16 | +7,181 | 10,632,981 | 0% | +$22,723 | |||||
| DM | 2019-10-02 | MCHX | Marchex Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $3.05 | +43,132 | 10,679,513 | 0% | +$131,571 | |||||
2019-10-07 | MIND | Mitcham Industries Inc | Blum Peter H | Dir | P - Purchase | $2.77 | +5,000 | 502,224 | +1% | +$13,850 | ||||||
| D | 2019-09-13 | MOBQ | Mobiquity Technologies, Inc. | Salkind Gene | Dir, 10% | P - Purchase | $0.02 | +175,000,000 | 266,318,355 | +192% | +$3,194,750 | |||||
2019-09-27 | NDRA | Endra Life Sciences Inc. | Wells David R. | CFO | P - Purchase | $1.18 | +10,000 | 44,786 | +29% | +$11,800 | ||||||
2019-09-30 | NE | Noble Corp Plc | Edwards Julie H | Dir | P - Purchase | $1.24 | +25,000 | 189,302 | +15% | +$30,990 | ||||||
| M | 2019-09-24 | NTN | Ntn Buzztime Inc | Ellin Robert S | 10% | P - Purchase | $2.51 | +28,700 | 343,958 | +9% | +$71,948 | |||||
| M | 2019-09-12 | NTN | Ntn Buzztime Inc | Ellin Robert S | 10% | P - Purchase | $2.26 | +9,002 | 315,258 | +3% | +$20,368 | |||||
2019-09-30 | OCGN | Ocugen, Inc. | Zhang Junge | Dir | P - Purchase | $3.09 | +31,078 | 243,941 | +15% | +$96,141 | ||||||
2019-09-17 | OCX | Oncocyte Corp | Arno Andrew | Dir | P - Purchase | $2.16 | +50,000 | 102,447 | +95% | +$108,130 | ||||||
2019-09-13 | OCX | Oncocyte Corp | Kalajian Tony T | SVP-Chief Accounting Officer | P - Purchase | $1.98 | +10,000 | 10,000 | New | +$19,800 | ||||||
| D | 2019-09-27 | ONDS | Ondas Holdings Inc. | Brock Eric A | CEO, COB | P - Purchase | $2.50 | +400,000 | 5,473,585 | +8% | +$1,000,000 | |||||
| D | 2019-09-25 | ONTX | Onconova Therapeutics, Inc. | Marino James J | Dir | P - Purchase | $1.60 | +7,260 | 16,942 | +75% | +$11,616 | |||||
2019-09-17 | OTEL | Otelco Inc. | Sochet IRA | 10% | P - Purchase | $2.29 | +9,878 | 1,496,741 | +1% | +$22,637 | ||||||
2019-10-08 | OVID | Ovid Therapeutics Inc. | Levin Jeremy M | CEO, 10% | P - Purchase | $2.50 | +60,000 | 5,237,106 | +1% | +$150,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |